SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-051313
Filing Date
2022-09-27
Accepted
2022-09-27 08:01:27
Documents
1
Period of Report
2022-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5029
  Complete submission text file 0001209191-22-051313.txt   6498
Mailing Address 499 ILLINOIS STREET, SUITE 200 SAN FRANCISCO CA 94158
Business Address
Ehrlich Christopher B (Reporting) CIK: 0001293973 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 221267305

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations